Keywords: دیسکینزی خفیف; Tardive dyskinesia; Delphi; Genetics; Imaging; Nomenclature;
مقالات ISI دیسکینزی خفیف (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: دیسکینزی خفیف; Tardive dyskinesia; Spontaneous dyskinesia; Antipsychotic drugs; Schizophrenia; Chorea; Dystonia; Parkinsonism; Akathisia;
Keywords: دیسکینزی خفیف; Tardive syndromes; Tardive dyskinesia; Tardive dystonia; Deep brain stimulation; GPi; STN;
Keywords: دیسکینزی خفیف; Tardive syndrome; Tardive dyskinesia; Tardive dystonia; Tardive tremors; Tardive akathisia; Tardive tourettism; Tardive pain; Tardive parkinsonism; Extrapyramidal syndrome;
Keywords: دیسکینزی خفیف; Tardive dyskinesia; Tardive syndrome; Risk factors; Prevention; Therapeutic drug monitoring; Cytochrome;
Keywords: دیسکینزی خفیف; Abnormal Involuntary Movement Scale; Antipsychotic; Deutetrabenazine; Dopamine; Tardive dyskinesia; Valbenazine; VMAT2;
Keywords: دیسکینزی خفیف; Tardive dyskinesia; Tardive syndromes; Evidence-based guideline; Treatment algorithm;
Keywords: دیسکینزی خفیف; Tardive dyskinesia; Tardive syndrome; Valbenazine; Deutetrabenazine; VMAT2 inhibitor; Treatment;
Keywords: دیسکینزی خفیف; Tardive dyskinesia; Pharmacogenetics; Schizophrenia; Disrupted-In-Schizophrenia-1 (DISC1);
Keywords: دیسکینزی خفیف; Tardive dyskinesia; Tyrosine hydroxylase; Glutamic acid decarboxylase; Dopamine; Movement disorders;
Keywords: دیسکینزی خفیف; Tardive syndromes; Tardive dyskinesia; Dopamine receptor blocking agents; Neuroleptics; Stereotypy; Dystonia;
Keywords: دیسکینزی خفیف; 5-HT; serotonin; CLZ; clozapine; CTL; control; DAT; dopamine transporter; Dysk; dyskinetic; HAL; haloperidol; mGlu5; metabotropic glutamate type 5 receptor; N-Dysk; non-dyskinetic; TD; tardive dyskinesia; TH; tyrosine hydroxylase; VCM; vacuous chewing mov
Keywords: دیسکینزی خفیف; Abnormal Involuntary Movement Scale; Antipsychotic; Deutetrabenazine; Dopamine; Tardive dyskinesia; Valbenazine; VMAT2;
Keywords: دیسکینزی خفیف; Ataxia; chorea; dystonia; myoclonus; tardive dyskinesia; tics; Tourette's syndrome; tremor
Keywords: دیسکینزی خفیف; Stereotypy; Adult; Frontotemporal dementia; Tardive dyskinesia; Treatment; Stéréotypie; Adulte; Démence frontotemporale; Dyskinésie tardive; Traitement;
Keywords: دیسکینزی خفیف; Antipsychotic; Deficit syndrome; Relapse; Tardive dyskinesia; Treatment-resistant;
Keywords: دیسکینزی خفیف; Tardive dystonia; Tardive dyskinesia; Pallidal stimulation; Deep brain stimulation; Globus pallidus
Keywords: دیسکینزی خفیف; Antipsychotic drugs; Schizophrenia; Tardive dyskinesia; Catatonia; Neuroleptic malignant syndrome; Akathisia; Parkinsonism; Dystonia;
Keywords: دیسکینزی خفیف; Antipsychotics; Clinical course; Deficit syndrome; Dopamine D2 receptor; Prognosis; Tardive dyskinesia; Treatment-resistant;
Keywords: دیسکینزی خفیف; Movement disorder; Drugs; Dopamine receptor; Tardive dyskinesia; Tardive Dystonia;
Keywords: دیسکینزی خفیف; Clozapine; Tardive syndromes; Tardive dystonia; Tardive dyskinesia;
Keywords: دیسکینزی خفیف; Tardive syndrome; Tardive dyskinesia; Antipsychotics
Keywords: دیسکینزی خفیف; ANOVA; analysis of variance; CB1; cannabinoid receptor 1; D2; dopamine receptor 2; L-DOPA; l-3,4-dihydroxyphenylalanine; OD; orofacial dyskinesia; MAO; monoaminoxidase; PBS; phosphate buffered saline; SR141716A; 5-(4-chlorophenyl)-1-(2,4-dichloro-phenyl)-
Keywords: دیسکینزی خفیف; Schizophrenia; Tardive dyskinesia; Cognition; Superoxide dismutase; Oxidative stress;
Keywords: دیسکینزی خفیف; Nebivolol; Tardive dyskinesia; Vacuous chewing movements;
Keywords: دیسکینزی خفیف; TD; tardive dyskinesia; ROS; reactive oxygen species; NOS; reactive nitrogen species; NO; nitric oxide; H2O2; hydrogen peroxide; O2â; superoxide radical; OH; hydroxyl radical; SOD; superoxidase dismutases; redox; reduction-oxidation; PUFA; polyunsatur
Keywords: دیسکینزی خفیف; TD; tardive dyskinesia; RBANS; Assessment of Neuropsychological Status; PANSS; Positive and Negative Symptom Scale; AIMS; Abnormal Involuntary Movement Scale; CLAT; conceptual analogy test; MMSE; mini-mental state examination; ANOVA; analysis of variance;
Keywords: دیسکینزی خفیف; Clozapine; Tardive syndromes; Tardive dyskinesia; Tardive dystonia;
Keywords: دیسکینزی خفیف; Tardive dystonia; Tardive dyskinesia; Pallidal stimulation; Deep brain stimulation; Globus pallidus
VMAT2 inhibitors for the treatment of tardive dyskinesia
Keywords: دیسکینزی خفیف; Tardive dyskinesia; Tardive syndrome; VMAT2 inhibitors; Valbenazine; Deutetrabenazine;
Non-VMAT2 inhibitor treatments for the treatment of tardive dyskinesia
Keywords: دیسکینزی خفیف; Tardive dyskinesia; Drug-induced dyskinesia;
MSBIS: A Multi-Step Biomedical Informatics Screening Approach for Identifying Medications that Mitigate the Risks of Metoclopramide-Induced Tardive Dyskinesia
Keywords: دیسکینزی خفیف; Tardive dyskinesia; Metoclopramide; Drug safety; Drug-drug interactions; Drug repurposing; Combination therapy;
Association between DBH 19Â bp insertion/deletion polymorphism and cognition in schizophrenia with and without tardive dyskinesia
Keywords: دیسکینزی خفیف; Schizophrenia; Tardive dyskinesia; Dopamine beta-hydroxylase; Cognition; Genotype;
Association study of MiRSNPs with schizophrenia, tardive dyskinesia and cognition
Keywords: دیسکینزی خفیف; MiRSNP; Schizophrenia; Tardive dyskinesia; Cognition; Association study; 3â²-Untranslated region (3â²-UTR);
Research reportBeneficial effects of EGb761 and vitamin E on haloperidol-induced vacuous chewing movements in rats: Possible involvement of S100B mechanisms
Keywords: دیسکینزی خفیف; Gingko biloba leaf extract; Vitamin E; Tardive dyskinesia; S100B;
Dyskinésies tardives induites par les antipsychotiques : données actuelles sur leur prévention et prise en charge
Keywords: دیسکینزی خفیف; Dyskinésies tardives; Dystonies tardives; Antipsychotiques; Neuroleptiques; Iatrogénie; Tardive dyskinesia; Tardive dystonia; Antipsychotic drugs; Neuroleptics; Iatrogenic disease;
Research PaperStriatal cholinergic interneurons and D2 receptor-expressing GABAergic medium spiny neurons regulate tardive dyskinesia
Keywords: دیسکینزی خفیف; ANOVA; analysis of variance; TD; tardive dyskinesia; nAChR; nicotinic acetylcholine receptor; *; the asterisk indicates the possible presence of other subunits in the nicotinic receptor complex; Cholinergic interneurons; D2 receptor-expressing neurons; GA
Ginkgo biloba leaf extract and alpha-tocopherol attenuate haloperidol-induced orofacial dyskinesia in rats: Possible implication of antiapoptotic mechanisms by preventing Bcl-2 decrease and Bax elevation
Keywords: دیسکینزی خفیف; Ginkgo biloba leaf extract (EGb761); Alpha-tocopherol; Tardive dyskinesia; Bax/Bcl-2; ANCOVA; analysis of covariance; ANOVA; analysis of variance (ANOVA); BDNF; brain-derived neurotrophic factor; CAT; catalase; EGb761; Ginkgo biloba extract; GABA; gamma a
Orofacial Movement Disorders
Keywords: دیسکینزی خفیف; Orofacial dystonia; Orofacial dyskinesia; Tardive dyskinesia; Bruxism; Drug-induced extrapyramidal reactions;
Ginkgo biloba and vitamin E ameliorate haloperidol-induced vacuous chewingmovement and brain-derived neurotrophic factor expression in a rat tardive dyskinesia model
Keywords: دیسکینزی خفیف; Tardive dyskinesia; Extract of Ginkgo biloba; BDNF; Vacuous chewing movements;
Chronic levodopa treatment alters expression and function of dopamine D3 receptor in the MPTP/p mouse model of Parkinson's disease
Keywords: دیسکینزی خفیف; PD; Parkinson's disease; MPTP/p; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine plus probenecid; l-DOPA; levodopa; LID; levodopa-induced dyskinesia; MAPK; mitogen-activated protein kinase; pERK; phosphorylated extracellular signal-regulated kinase; tERK;
Altered IL-2, IL-6 and IL-8 serum levels in schizophrenia patients with tardive dyskinesia
Keywords: دیسکینزی خفیف; Schizophrenia; Tardive dyskinesia; Immune; Interleukin;
Trastornos del movimiento (III): Síndromes coreicos y distonía
Keywords: دیسکینزی خفیف; Enfermedad de Huntington; Enfermedad de Wilson; Corea de Sydenham; Hemibalismo; Discinesias tardías; DistoníasHuntington's disease; Wilson's disease; Sydenham's chorea; Hemiballismus; Tardive dyskinesia; Dystonia
Tardive dyskinesia in relation to estimated dopamine D2 receptor occupancy in patients with schizophrenia: Analysis of the CATIE data
Keywords: دیسکینزی خفیف; Abnormal involuntary movement; Antipsychotics; CATIE; Dopamine D2 receptor; Schizophrenia; Tardive dyskinesia;
Dehydroepiandrosterone sulphate as a putative protective factor against tardive dyskinesia
Keywords: دیسکینزی خفیف; AIC; Akaike's Information Criterion; AIMS; Abnormal Involuntary Movement Scale; CYP17; Cytochrome P450c17α; DHEA(S); Dehydroepiandrosterone (sulphate); HWE; Hardy-Weinberg equilibrium; MI; Multiple imputation; TD; Tardive dyskinesia; TDof; Orofacioling
Association of altered CuZn superoxide dismutase and cognitive impairment in schizophrenia patients with tardive dyskinesia
Keywords: دیسکینزی خفیف; Schizophrenia; Tardive dyskinesia; Cognition; Superoxide dismutase; Oxidative stress
BDNF Val66Met polymorphism and antipsychotic-induced tardive dyskinesia occurrence and severity: A meta-analysis
Keywords: دیسکینزی خفیف; Tardive dyskinesia; AIMS; BDNF; Genotype; Schizophrenia; Race;
Association study of the vesicular monoamine transporter gene SLC18A2 with tardive dyskinesia
Keywords: دیسکینزی خفیف; Tardive dyskinesia; Schizophrenia; Pharmacogenetics; Vesicular monoamine transporter 2 (VMAT2/SLC18A2); (TD); tardive dyskinesia; (VMAT2); vesicular monoamine transporter 2; (CATIE); Clinical Antipsychotic Trials of Intervention Effectiveness; (SNP); sing
Globus pallidus interna deep brain stimulation for tardive dyskinesia: Case report and review of the literature
Keywords: دیسکینزی خفیف; Tardive dyskinesia; Tardive dystonia; Deep brain stimulation; Pallidal stimulation; Globus pallidus;
Brain levels of the neurotoxic pyridinium metabolite HPP+ and extrapyramidal symptoms in haloperidol-treated mice
Keywords: دیسکینزی خفیف; Haloperidol; Adverse drug reaction; Tardive dyskinesia; Mouse; HPTP; HPP+